Function of the c-Myc Antagonist Mad1 during a Molecular Switch from Proliferation to Differentiation

REFERENCES

• Amati, B., M. W. Brooks, N. Levy, T. D. Littlewood, G. I. Evan, and H. Land. 1993. Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell 72:233–245.
   PubMed Web of Science ®Google Scholar
• Amati, B., S. Dalton, M. W. Brooks, T. D. Littlewood, G. I. Evan, and H. Land. 1992. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature 359:423–426.
   PubMed Web of Science ®Google Scholar
• Amin, C., A. J. Wagner, and N. Hay. 1993. Sequence-specific transcriptional activation by Myc and repression by Max. Mol. Cell. Biol. 13:383–390.
   PubMed Web of Science ®Google Scholar
• Ayer, D. E., and R. N. Eisenman. 1993. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev. 7:2110–2119.
   PubMed Web of Science ®Google Scholar
• Ayer, D. E., L. Kretzner, and R. N. Eisenman. 1993. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72:211–222.
   PubMed Web of Science ®Google Scholar
• Ayer, D. E., C. D. Laherty, Q. A. Lawrence, A. P. Armstrong, and R. N. Eisenman. 1996. Mad proteins contain a dominant transcription repression domain. Mol. Cell. Biol. 16:5772–5781.
   PubMed Web of Science ®Google Scholar
• Ayer, D. E., Q. A. Lawrence, and R. N. Eisenman. 1995. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80:767–776.
   PubMed Web of Science ®Google Scholar
• Bar-Ner, M., L. T. Messing, C. M. Cultraro, M. J. Birrer, and S. Segal. 1992. Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells. Cell Growth Differ. 3:183–190.
   PubMedGoogle Scholar
• Bello-Fernandez, C., G. Packham, and J. L. Clevland. 1993. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl. Acad. Sci. USA 90:7804–7808.
   PubMed Web of Science ®Google Scholar
• Blackwood, E. M., and R. N. Eisenman. 1991. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251:1211–1217.
   PubMed Web of Science ®Google Scholar
• Blackwood, E. M., B. Luscher, and R. N. Eisenman. 1992. Myc and Max associate in vivo. Genes Dev. 6:71–80.
   PubMed Web of Science ®Google Scholar
• Cerni, C., K. Bousset, C. Seelos, H. Burkhardt, M. Henriksson, and B. Luscher. 1995. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins. Oncogene 11:587–596.
   PubMed Web of Science ®Google Scholar
• Chen, J., T. Willingham, L. R. Margraf, N. Schreiber-Agus, R. A. DePinho, and P. D. Nisen. 1995. Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumor cells. Nat. Med. 1:638–643.
   PubMed Web of Science ®Google Scholar
• Chin, L., N. Schreiber-Agus, I. Pellicer, K. Chen, H. Lee, M. Dudast, C. Cordon-Cardo, and R. A. DePinho. 1995. Contrasting roles for Myc and Mad proteins in cellular growth and differentiation. Proc. Natl. Acad. Sci. USA 92:8488–8492.
   PubMed Web of Science ®Google Scholar
• Cogliati, T., B. K. Dunn, M. Bar-Ner, C. M. Cultraro, and S. Segal. 1993. Transfected wild-type and mutant max regulate cell growth and differentiation of murine erythroleukemia cells. Oncogene 8:1263–1268.
   PubMedGoogle Scholar
• Coppola, J. A., and M. D. Cole. 1986. Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment. Nature 320:760–763.
   PubMed Web of Science ®Google Scholar
• Cowell, I. G. 1994. Repression versus activation in the control of gene transcription. Trends Biochem. Sci. 19:38–42.
   PubMed Web of Science ®Google Scholar
• Crouch, D. H., C. Lang, and D. A. F. Gillespie. 1990. The leucine zipper domain of avian c-Myc is required for transformation and autoregulation. Oncogene 5:683–689.
   PubMedGoogle Scholar
• Cultraro, C. M., T. Cogliati, L. E. Hearing, and S. Segal. 1996. Basic mutant Max reverses a c-Myc block to differentiation. Oncol. Rep. 3:141–146.
   PubMedGoogle Scholar
• Davis, L. G., M. D. Dibner, and J. F. Battey. 1986. Basic methods in molecular biology. Elsevier Science Publishing Co., New York, N.Y.
   Google Scholar
• Delgado, M. D., A. Lerga, M. Canelles, M. T. Gomez-Casares, and J. Leon. 1995. Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells. Oncogene 10:1659–1665.
   PubMed Web of Science ®Google Scholar
• Dmitrovsky, E., W. M. Kuehl, G. F. Hollis, I. R. Kirsch, T. P. Bender, and S. Segal. 1986. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line. Nature 322:748–750.
   PubMed Web of Science ®Google Scholar
• Dube, S. K., G. Gaedicke, G. Kluge, N. Weimann, B. J. Melderis, H. Stein-heider, G. Crozier, H. Beckmann, and W. Ostertag. 1974. Hemoglobin-synthesizing mouse and human erythroleukemic cell lines as model systems for the study of differentiation and control of gene expression, p. 99–135. In W. Nakar, T. Ono, T. Suigimura, and H. Sugano (ed.), Differentiation and control of malignancy in tumor cells. University of Tokyo Press, Tokyo, Japan.
   Google Scholar
• Dunn, B. K., T. Cogliati, C. M. Cultraro, M. Bar-Ner, and S. Segal. 1994. Regulation of murine Max (Myn) parallels the regulation of c-Myc in differentiating murine erythroleukemia cells. Cell Growth Differ. 5:847–854.
   PubMedGoogle Scholar
• Edelhoff, S., D. E. Ayer, A. S. Zervos, E. Steingrimsson, N. A. Jenkins, N. G. Copeland, R. N. Eisenman, R. Brent, and C. M. Disteche. 1994. Mapping of two genes encoding members of a distinct subfamily of MAX interacting proteins: MAD to human chromosome 2 and mouse chromosome 6, and MXI1 to human chromosome 10 and mouse chromosome 19. Oncogene 9:665–668.
   PubMed Web of Science ®Google Scholar
• Eilers, M., S. Schirm, and J. M. Bishop. 1991. The MYC protein activates transcription of the a-prothymosin gene. EMBO J. 10:133–141.
   PubMed Web of Science ®Google Scholar
• Einat, M., D. Resnitzky, and A. Kimchi. 1985. Close link between reduction of c-myc expression by interferon and G0/G1 arrest. Nature 313:597–600.
   PubMed Web of Science ®Google Scholar
• Freytag, S. O. 1988. Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1. Mol. Cell. Biol. 8:1614–1624.
   PubMed Web of Science ®Google Scholar
• Gu, W., K. Cechova, V. Tassi, and R. Dalla-Favera. 1993. Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. Proc. Natl. Acad. Sci. USA 90:2935–2939.
   PubMedGoogle Scholar
• Harper, S. E., Y. Qiu, and P. Sharp. 1996. Sin3 corepressor function in Myc-induced transcription and transformation. Proc. Natl. Acad. Sci. USA 93:8536–8540.
   PubMed Web of Science ®Google Scholar
• Henriksson, M., and G. Luscher. 1996. Proteins of the Myc network: essential regulators of cell growth and differentiation. Cancer Res. 68:110–182.
   Google Scholar
• Hurlin, P. J., K. P. Foley, D. E. Ayer, R. N. Eisenman, D. Hanahan, and J. M. Arbeit. 1995. Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis. Oncogene 11:2487–2501.
   PubMed Web of Science ®Google Scholar
• Hurlin, P. J., C. Queva, D. E. Ayer, N. G. Copeland, N. A. Jenkins, and R. N. Eisenman. 1995. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J. 14:5646–5659.
   PubMed Web of Science ®Google Scholar
• Kaczmarek, L., J. K. Hyland, R. Watt, M. Rosenberg, and R. Baserga. 1985. Microinjected c-myc as a competence factor. Science 228:1313–1315.
   PubMed Web of Science ®Google Scholar
• Kahn, S. M., W. Jiang, C. Borner, K. O’Driscoll, and I. B. Weinstein. 1990. Construction of defined deletion mutants by thermal cycled fusion: applications to protein kinase C. Tech. J. Methods Cell Mol. Biol. 2:27–30.
   Google Scholar
• Kato, G., W. M. F. Lee, L. Chen, and C. V. Dang. 1992. Max: functional domains and interaction with c-Myc. Genes Dev. 6:81–92.
   PubMed Web of Science ®Google Scholar
• Kato, G. J., J. Barrett, M. Villa-Garcia, and C. V. Dang. 1990. An amino-terminal c-Myc domain required for neoplastic transformation activates transcription. Mol. Cell. Biol. 10:5914–5920.
   PubMed Web of Science ®Google Scholar
• Klinken, P. S., K. L. Holmes, H. C. Morse, and S. S. Thorgeirsson. 1988. Transcriptional and post-transcriptional regulation of c-myc and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO. Exp. Cell Res. 178:185–198.
   PubMedGoogle Scholar
• Koskinen, P. J., D. E. Ayer, and R. N. Eisenman. 1995. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions. Cell Growth Differ. 6:623–629.
   PubMedGoogle Scholar
• Kretzner, L., E. M. Blackwood, and R. N. Eisenman. 1992. Myc and Max proteins possess distinct transcriptional activities. Nature 359:426–429.
   PubMed Web of Science ®Google Scholar
• Lachman, H. M., and A. I. Skoultchi. 1984. Expression of c-myc changes during differentiation of mouse erythroleukemia cells. Nature 310:592–594.
   PubMed Web of Science ®Google Scholar
• Lahoz, E. G., L. Xu, N. Schreiber-Agus, and R. A. DePinho. 1994. Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1. Proc. Natl. Acad. Sci. USA 91:5503–5507.
   PubMed Web of Science ®Google Scholar
• Larsson, L., M. Pettersson, F. Oberg, K. Nilsson, and B. Luscher. 1994. Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. Oncogene 9:1247–1252.
   PubMed Web of Science ®Google Scholar
• Levine, M., and J. L. Manley. 1989. Transcriptional repression of eukaryotic promoters. Cell 59:405–408.
   PubMedGoogle Scholar
• Littlewood, T. D., B. Amati, H. Land, and G. I. Evan. 1992. Max and c-Myc/Max DNA-binding activities in cell extracts. Oncogene 7:1783–1792.
   PubMed Web of Science ®Google Scholar
• Lymboussaki, A., A. Kaipainen, E. Hatva, I. Vastrik, L. Jeskanen, M. Jal-kanen, S. Werner, R. Stenback, and R. Alitalo. 1996. Expression of Mad, an antagonist of Myc oncoprotein function, in differentiating keratinocytes during tumorigenesis of the skin. Br. J. Cancer 73:1347–1355.
   PubMedGoogle Scholar
• Marcu, K. B., S. A. Bossone, and A. J. Patel. 1992. myc function and regulation. Annu. Rev. Biochem. 61:809–860.
   PubMed Web of Science ®Google Scholar
• Marks, P. A., V. M. Richon, J. Kiyokawa, and R. A. Rifkind. 1994. Inducing differentiation of transformed cells with hybrid polar compounds: a cell cycle-dependent process. Proc. Natl. Acad. Sci. USA 91:10251–10254.
   PubMed Web of Science ®Google Scholar
• Mechti, N., M. Piechaczyk, J. Blanchard, L. Marty, A. Bonnieu, P. Jeanteur, and B. Lebleu. 1986. Transcriptional and posttranscriptional regulation of c-myc expression during differentiation of murine erythroleukemia Friend cells. Nucleic Acids Res. 14:9653–9666.
   PubMed Web of Science ®Google Scholar
• Miltenberger, R. J., K. A. Sukow, and P. J. Farnham. 1995. An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants. Mol. Cell. Biol. 15:2527–2535.
   PubMed Web of Science ®Google Scholar
• Min, S., and E. J. Taparowsky. 1992. v-Myc, but not Max, possesses domains that function in both transcription activation and cellular transformation. Oncogene 7:1531–1540.
   PubMedGoogle Scholar
• Mukherjee, B., S. D. Morgenbesser, and R. A. DePinho. 1992. Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants. Genes Dev. 6:1480–1492.
   PubMedGoogle Scholar
• Nepveu, A., K. B. Marcu, A. I. Skoultchi, and H. M. Lachman. 1987. Contributions of transcriptional and post-transcriptional mechanisms to the regulation of c-myc expression in mouse erythroleukemia cells. Genes Dev. 1:938–945.
   PubMedGoogle Scholar
• Pena, A., C. D. Reddy, S. Wu, N. J. Hickok, E. P. Reddy, G. Yumet, D. R. Soprano, and K. J. Soprano. 1993. Regulation of human ornithine decar-boxylase expression by the c-Myc:Max protein complex. J. Biol. Chem. 268:27277–27285.
   PubMedGoogle Scholar
• Prendergast, G. C., R. Hopewell, R. J. Gorham, and E. B. Ziff. 1992. Biphasic effect of Max on Myc cotransformation activity and dependence on amino-and carboxy-terminal Max functions. Genes Dev. 6:2429–2439.
   PubMed Web of Science ®Google Scholar
• Prendergast, G. C., D. Lawe, and E. B. Ziff. 1991. Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and Ras cotransformation. Cell 65:395–407.
   PubMed Web of Science ®Google Scholar
• Prochownik, E. V., and J. Kukowska. 1986. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation. Nature 322:848–850.
   PubMed Web of Science ®Google Scholar
• Prochownik, E. V., J. Kukowska, and C. Rodgers. 1988. c-myc antisense transcripts accelerate differentiation and inhibit G1 progression in murine erythroleukemia cells. Mol. Cell. Biol. 8:3683–3695.
   PubMed Web of Science ®Google Scholar
• Rao, G., L. Alland, P. Guida, N. Schreiber-Agus, K. Chen, L. Chin, J. M. Rochelle, M. F. Seldin, A. I. Skoultchi, and R. A. DePinho. 1996. Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression domain of the Myc antagonist Mxi1. Oncogene 12:1165–1172.
   PubMedGoogle Scholar
• Reddy, C. D., P. Dasgupta, P. Saikumar, H. Dudek, F. Rauscher, and E. P. Reddy. 1992. Mutational analysis of Max: role of basic, helix-loop-helix/ leucine zipper domains in DNA binding, dimerization and regulation of Myc-mediated transcriptional activation. Oncogene 7:2085–2092.
   PubMedGoogle Scholar
• Roussel, M. F., R. A. Ashmun, C. J. Sherr, R. N. Eisenman, and D. E. Ayer. 1996. Inhibition of cell proliferation by the Mad1 transcriptional repressor. Mol. Cell. Biol. 16:2796–2801.
   PubMed Web of Science ®Google Scholar
• Roy, B., and D. Reisman. 1995. Inducible expression of Mad accelerates growth arrest of serum deprived human glioblastoma cells. Cell Biol. Int. 19:307–313.
   PubMed Web of Science ®Google Scholar
• Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Schreiber-Agus, N., L. Chin, K. Chen, R. Torres, G. Rao, P. Guida, A. I. Skoultchi, and R. A. DePinho. 1995. An amino-terminal domain of Mxi1 mediates Anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor Sin3. Cell 80:777–786.
   PubMed Web of Science ®Google Scholar
• Shapiro, D. N., V. Valentine, L. Eagle, X. Yin, S. W. Morris, and E. V. Prochownik. 1994. Assignment of the human MAD and MXI1 genes to chromosomes 2p12-p13 and 10q24-25. Genomics 23:282–285.
   PubMed Web of Science ®Google Scholar
• Spotts, G. D., and S. R. Hann. 1990. Enhanced translation and increased turnover of c-myc proteins occur during differentiation of murine erythro-leukemia cells. Mol. Cell. Biol. 10:3952–3964.
   PubMedGoogle Scholar
• Stone, J., T. de Lange, G. Ramsay, E. Jakobovits, J. M. Bishop, H. Varmus, and W. Lee. 1987. Definition of region in human c-myc that are involved in transformation and nuclear localization. Mol. Cell. Biol. 7:1697–1709.
   PubMed Web of Science ®Google Scholar
• Vastrik, I., A. Kaipainen, T. Penttila, A. Lymboussakis, R. Alitalo, M. Par-vinen, and K. Alitalo. 1995. Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro. J. Cell Biol. 128:1197–1208.
   PubMedGoogle Scholar
• Wagner, A. J., C. Meyers, A. Laimins, and N. Hay. 1993. c-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ. 4:879–883.
   PubMedGoogle Scholar
• Zervos, A. S., J. Gyuris, and R. Brent. 1993. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72:223–232.
   PubMed Web of Science ®Google Scholar